European Pharmaceutical Market Access, Pricing and Reimbursement

London, United Kingdom (October, 10 - 11, 2016)

SMi Group’s 22nd annual European Pharmaceutical Market Access, Pricing and Reimbursement conference returns to London from 10-11 October 2016. The conference is one of the most established in the world, focusing on the changes in pricing and reimbursement and market access.

This year's agenda will have a strong focus on the future of pricing and reimbursement. Other key topics include:

• Updates on AMNOG and its implication on pricing and reimbursement
• How biosimilars are affecting your pricing strategy
• Capture on emerging markets’ regulatory framework to adapt your market access and P&R models
• Orphan drugs using recent examples to highlight the impact on pricing
• Cancer drug funding and budget cuts in the UK
• Innovative solutions beyond the pill
• Japanese and Turkish regional updates

For more information please visit: www.pharmaceuticalpricing.co.uk

To register: contact Fateja Begum on +44 (0)20 7827 6184 or email: fbegum@smi-online.co.uk